 | • レポートコード：B-GIR09D3830 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、がんホルモン療法薬の世界市場について調べ、まとめました。種類別セグメントは、タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他等、用途別セグメントは、乳がん、前立腺がん等に区分しました。がんホルモン療法薬の世界市場概観、企業動向、企業別がんホルモン療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がんホルモン療法薬の市場概観 ・がんホルモン療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がんホルモン療法薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・がんホルモン療法薬の世界市場規模 ・がんホルモン療法薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・がんホルモン療法薬のアメリカ市場規模推移 ・がんホルモン療法薬のカナダ市場規模推移 ・がんホルモン療法薬のメキシコ市場規模推移 ・がんホルモン療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・がんホルモン療法薬のドイツ市場規模推移 ・がんホルモン療法薬のイギリス市場規模推移 ・がんホルモン療法薬のロシア市場規模推移 ・がんホルモン療法薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・がんホルモン療法薬の日本市場規模推移 ・がんホルモン療法薬の中国市場規模推移 ・がんホルモン療法薬の韓国市場規模推移 ・がんホルモン療法薬のインド市場規模推移 ・がんホルモン療法薬の東南アジア市場規模推移 ・がんホルモン療法薬の南米市場分析（ブラジル、アルゼンチン等） ・がんホルモン療法薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・がんホルモン療法薬の種類別分析/販売量、売上、市場シェア（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他） ・がんホルモン療法薬の用途別分析/市場規模（乳がん、前立腺がん） ・がんホルモン療法薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・がんホルモン療法薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
Scope of the Report:
The global Cancer Hormone Therapy Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Hormone Therapy Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Hormone Therapy Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Hormone Therapy Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Market Segment by Applications, can be divided into
Breast Cancer
Prostate Cancer
Table of Contents
1 Cancer Hormone Therapy Drugs Market Overview
1.1 Product Overview and Scope of Cancer Hormone Therapy Drugs
1.2 Classification of Cancer Hormone Therapy Drugs by Types
1.2.1 Global Cancer Hormone Therapy Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Types in 2018
1.2.3 Tamoxifen
1.2.4 Aromatase Inhibitors
1.2.5 Antiandrogens
1.2.6 Androgen Synthesis Inhibitors
1.2.7 Other
1.3 Global Cancer Hormone Therapy Drugs Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Global Cancer Hormone Therapy Drugs Market by Regions
1.4.1 Global Cancer Hormone Therapy Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Hormone Therapy Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Cancer Hormone Therapy Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Cancer Hormone Therapy Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Cancer Hormone Therapy Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Teva
2.4.1 Business Overview
2.4.2 Cancer Hormone Therapy Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Takeda
2.5.1 Business Overview
2.5.2 Cancer Hormone Therapy Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Samyang Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Cancer Hormone Therapy Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Tolmar
2.7.1 Business Overview
2.7.2 Cancer Hormone Therapy Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Cancer Hormone Therapy Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Cancer Hormone Therapy Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 Aspen
2.10.1 Business Overview
2.10.2 Cancer Hormone Therapy Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Hormone Therapy Drugs Market Competition, by Players
3.1 Global Cancer Hormone Therapy Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Hormone Therapy Drugs Players Market Share
3.2.2 Top 10 Cancer Hormone Therapy Drugs Players Market Share
3.3 Market Competition Trend
4 Global Cancer Hormone Therapy Drugs Market Size by Regions
4.1 Global Cancer Hormone Therapy Drugs Revenue and Market Share by Regions
4.2 North America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
5 North America Cancer Hormone Therapy Drugs Revenue by Countries
5.1 North America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
5.2 USA Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
6 Europe Cancer Hormone Therapy Drugs Revenue by Countries
6.1 Europe Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
6.2 Germany Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
6.4 France Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Countries
7.1 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
7.2 China Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
7.5 India Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
8 South America Cancer Hormone Therapy Drugs Revenue by Countries
8.1 South America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
8.2 Brazil Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Hormone Therapy Drugs by Countries
9.1 Middle East and Africa Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
10 Global Cancer Hormone Therapy Drugs Market Segment by Type
10.1 Global Cancer Hormone Therapy Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Hormone Therapy Drugs Market Forecast by Type (2019-2024)
10.3 Tamoxifen Revenue Growth Rate (2014-2024)
10.4 Aromatase Inhibitors Revenue Growth Rate (2014-2024)
10.5 Antiandrogens Revenue Growth Rate (2014-2024)
10.6 Androgen Synthesis Inhibitors Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Cancer Hormone Therapy Drugs Market Segment by Application
11.1 Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2014-2019)
11.2 Cancer Hormone Therapy Drugs Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2014-2019)
11.4 Prostate Cancer Revenue Growth (2014-2019)
12 Global Cancer Hormone Therapy Drugs Market Size Forecast (2019-2024)
12.1 Global Cancer Hormone Therapy Drugs Market Size Forecast (2019-2024)
12.2 Global Cancer Hormone Therapy Drugs Market Forecast by Regions (2019-2024)
12.3 North America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
12.6 South America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Hormone Therapy Drugs Picture
Table Product Specifications of Cancer Hormone Therapy Drugs
Table Global Cancer Hormone Therapy Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Hormone Therapy Drugs Revenue Market Share by Types in 2018
Figure Tamoxifen Picture
Figure Aromatase Inhibitors Picture
Figure Antiandrogens Picture
Figure Androgen Synthesis Inhibitors Picture
Figure Other Picture
Table Global Cancer Hormone Therapy Drugs Revenue (Million USD) by Application (2014-2024)
Figure Cancer Hormone Therapy Drugs Revenue Market Share by Applications in 2018
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Table Global Market Cancer Hormone Therapy Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Hormone Therapy Drugs Type and Applications
Table Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Hormone Therapy Drugs Type and Applications
Table Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Hormone Therapy Drugs Type and Applications
Table Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Hormone Therapy Drugs Type and Applications
Table Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Hormone Therapy Drugs Type and Applications
Table Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Samyang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Type and Applications
Table Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Tolmar Basic Information, Manufacturing Base and Competitors
Table Tolmar Cancer Hormone Therapy Drugs Type and Applications
Table Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Hormone Therapy Drugs Type and Applications
Table AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Hormone Therapy Drugs Type and Applications
Table Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Cancer Hormone Therapy Drugs Type and Applications
Table Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Hormone Therapy Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue Share by Players (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Players in 2017
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Hormone Therapy Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Hormone Therapy Drugs Revenue Market Share in 2018
Figure Global Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Market Share by Regions in 2018
Figure North America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure South America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table North America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
Table North America Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Hormone Therapy Drugs Revenue Market Share by Countries in 2018
Figure USA Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Europe Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Hormone Therapy Drugs Revenue Market Share by Countries in 2018
Figure Germany Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure UK Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure France Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Share by Countries in 2018
Figure China Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure India Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table South America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
Table South America Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Hormone Therapy Drugs Revenue Market Share by Countries in 2018
Figure Brazil Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Type in 2019
Table Global Cancer Hormone Therapy Drugs Revenue Forecast by Type (2019-2024)
Figure Global Cancer Hormone Therapy Drugs Market Share Forecast by Type (2019-2024)
Figure Global Tamoxifen Revenue Growth Rate (2014-2019)
Figure Global Aromatase Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Antiandrogens Revenue Growth Rate (2014-2019)
Figure Global Androgen Synthesis Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue by Application (2014-2019)
Table Global Cancer Hormone Therapy Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue Share by Application in 2019
Table Global Cancer Hormone Therapy Drugs Revenue Forecast by Application (2019-2024)
Figure Global Cancer Hormone Therapy Drugs Market Share Forecast by Application (2019-2024)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Hormone Therapy Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Hormone Therapy Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
Figure Europe Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
Figure South America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
世界の癌治療における新薬デリバリーシステム市場予測（～2024年） Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. …- 世界の胆管がん治療薬市場予測（～2024年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…
- 世界の腫瘍薬市場予測（～2024年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: Oncology Drugs is widely used For Blood Cancer, Bre…
- 世界の紫斑療法薬市場予測（～2024年） Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis Scope of the Report: The worldwide market for Purpura Therapy Drugs is expected to grow at a CAGR of roughly xx% over the next five ye…
- 世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…